Zenas BioPharma, Inc. (ZBIO)

Healthcare · Biotechnology · NASDAQ

Zenas BioPharma, Inc. (ZBIO) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.05B and a free-cash-flow yield of -14.3%. Over the most recent reported fiscal year, revenue grew 100.0%.

Market cap	$2.05B
Trailing P/E	—
FCF yield	-14.3%
Revenue growth (YoY)	+100.0%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live ZBIO data on Nama Insights →